Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Achondroplasia

  • Author: Shital Parikh, MD; Chief Editor: Jeffrey D Thomson, MD  more...
 
Updated: Mar 29, 2016
 

Background

The skeletal dysplasias are a heterogeneous group of disorders characterized by intrinsic abnormalities in the growth and/or remodeling of cartilage and bone. These dysplasias affect the skull, spine, and extremities in varying degrees.[1] They frequently cause a disproportionately short stature (dwarfism); the standing height falls below the third percentile for age. Achondroplasia is the most common type of short-limb disproportionate dwarfism.

The term achondroplasia, implying absent cartilage formation, was first used by Parrot in 1878.[2] Although the word achondroplasia is inaccurate from a histopathologic perspective, its use is universal and accepted by the International Working Group on Constitutional Diseases of the Bone.[3, 4, 5]

Next

Anatomy

The bony skeleton is divided into two parts: the axial skeleton and the appendicular skeleton. The axial skeleton is the central core unit, consisting of the skull, vertebrae, ribs, and sternum. The appendicular skeleton comprises the bones of the extremities. For more information about the relevant anatomy, see Skeletal System Anatomy in Children and Toddlers, Skeletal System Anatomy in Adults, and Osteology (Bone Anatomy).

Previous
Next

Pathophysiology

Dwarfing conditions are frequently referred to as short-limb or short-trunk types, according to whether the trunk or limbs are more extensively involved. Achondroplasia, hypochondroplasia, and metaphyseal chondrodysplasias are considered short-limb dwarfing conditions. These patients' sitting height is within normal range. Additional terms used to describe the segment of the limb with the greatest involvement are rhizomelic (proximal), mesomelic (middle), and acromelic (distal). In achondroplasia, the extremity involvement is rhizomelic, with the arms and thighs more severely involved than the forearms, legs, hands, and feet.[6]

The primary defect found in patients with achondroplasia is abnormal endochondral ossification. Periosteal and intramembranous ossification is normal. Tubular bones are short and broad, reflecting normal periosteal growth. The iliac crest apophyses (appositional growth) are normal, giving rise to large, square iliac wings. The growth of the triradiate cartilage (endochondral growth) is abnormal, giving rise to horizontal acetabular roofs. Thus, the patterns of defect help to explain many of the observed clinical and radiographic characteristics of achondroplasia.

The characteristic features of achondroplasia are apparent at birth. The diagnosis is made on the basis of physical examination and radiographic findings.

Previous
Next

Etiology

Genetic basis

A single gene mapped to the short arm of chromosome 4 (band 4p16.3) is responsible for achondroplasia and is transmitted as an autosomal dominant trait.[7]

At least 80% of cases result from a random new mutation. In sporadic cases, a paternal age older than 36 years is common. Most parents are of average size and have no family history of a dwarfing condition. The risk of the parents producing a second affected child is almost negligible. Reports have estimated that there is a 1 in 443 risk of recurrence of achondroplasia in the siblings of an affected child with unaffected parents. This is because of gonadal mosaicism in the parents. Average-sized siblings have no increased risk of producing a child with achondroplasia.

When both parents have achondroplasia, 50% of their offspring are heterozygous and affected, 25% are homozygous, which is ordinarily fatal in the first few months of life, and 25% are unaffected. When one parent has achondroplasia, the chance of transmitting this gene to each child is 50%.

Molecular basis

Fibroblast growth factors (FGFs) are structurally related proteins associated with cell growth, migration, wound healing, and angiogenesis. At the cellular level, their function is mediated by transmembrane tyrosine kinase receptors, known as FGF receptors (FGFRs).[8]

Mutation in FGFR3 is responsible for achondroplasia, hypochondroplasia, and thanatophoric dysplasia.[8] The primary function of FGFR3 is to limit osteogenesis. Mutation causes enhancement in its function of limiting endochondral ossification. Mutation in FGFR3 in achondroplasia is due to transition of guanine to adenine (G to A) at nucleotide 1138 of complimentary DNA.

Associated syndrome

Two reports exist of achondroplasia associated with Down syndrome.[9] On the basis of the current birth rate, the calculated risk of association is 1 case in every 8 years in the United States.

Previous
Next

Epidemiology

Approximately 10,000 individuals are estimated to have achondroplasia in the United States. Worldwide, achondroplasia is the most common skeletal dysplasia, affecting about 1 in every 40,000 children. (This number varies, depending on the source.) About 80% of all "little people" have achondroplasia. Approximately 150,000 persons have achondroplasia worldwide. The worldwide population of little people is approximately 190,000.

Achondroplasia occurs with equal frequency in males and females. (It is inherited in an autosomal dominant manner.) Achondroplasia occurs in all the races with equal frequency.

Previous
Next

Prognosis

The standardized mortality ratio is increased for all age groups by a factor of 2.27 over that of the general population.[10] In children younger than 4 years, death most commonly occurs as a consequence of brainstem compression, which causes sudden death. In individuals aged 5-24 years, central nervous system (CNS) and respiratory abnormalities are the common causes of death. In persons aged 25-54 years, cardiovascular problems are the most frequent causes of death.

Morbidity associated with achondroplasia may include the following:

  • Recurrent otitis media (hearing loss)
  • Neurologic complications due to cervicomedullary compression (eg, hypotonia, respiratory insufficiency, apnea, cyanotic episodes, feeding problems, quadriparesis, sudden death) [1]
  • Obstructive and restrictive respiratory complications (eg, upper airway obstruction, pneumonia, apnea)
  • Spinal deformities (eg, kyphosis, lordosis, scoliosis)
  • Obesity [11, 12]
  • Spinal canal stenosis
  • Cardiovascular complications
Previous
Next

Patient Education

An important resource for individuals with short stature is the Little People of America. This is a national organization that addresses the social, physical, and medical needs of its constituency. It holds annual regional and national conventions. Philosophically, these organizations emphasize the positive aspects of their members' abilities and lives rather than viewing the issue of short stature as a disability.

The Dwarf Athletic Association of America is a member of the US Olympic Committee that promotes athletic participation for individuals with short stature.

When addressing height issues in patients with short stature, the term "less than average" should be used.

Previous
 
 
Contributor Information and Disclosures
Author

Shital Parikh, MD Associate Professor, Department of Pediatric Orthopedic Surgery, Cincinnati Children's Hospital Medical Center

Shital Parikh, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Medical Association, Orthopaedic Research Society

Disclosure: Nothing to disclose.

Coauthor(s)

Preeti Batra, MD, MBBS Staff Physician, Department of Radiology, VS Hospital, India

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

George H Thompson, MD Director of Pediatric Orthopedic Surgery, Rainbow Babies and Children’s Hospital, University Hospitals Case Medical Center, and MetroHealth Medical Center; Professor of Orthopedic Surgery and Pediatrics, Case Western Reserve University School of Medicine

George H Thompson, MD is a member of the following medical societies: American Orthopaedic Association, Scoliosis Research Society, Pediatric Orthopaedic Society of North America, American Academy of Orthopaedic Surgeons

Disclosure: Received none from OrthoPediatrics for consulting; Received salary from Journal of Pediatric Orthopaedics for management position; Received none from SpineForm for consulting; Received none from SICOT for board membership.

Chief Editor

Jeffrey D Thomson, MD Associate Professor, Department of Orthopedic Surgery, University of Connecticut School of Medicine; Director of Orthopedic Surgery, Department of Pediatric Orthopedic Surgery, Associate Director of Clinical Affairs for the Department of Surgical Subspecialties, Connecticut Children’s Medical Center; President, Connecticut Children's Specialty Group

Jeffrey D Thomson, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons

Disclosure: Nothing to disclose.

Additional Contributors

Mininder S Kocher, MD, MPH Associate Professor of Orthopedic Surgery, Harvard Medical School/Harvard School of Public Health; Associate Director, Division of Sports Medicine, Department of Orthopedic Surgery, Children's Hospital Boston

Mininder S Kocher, MD, MPH is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Sports Medicine, Pediatric Orthopaedic Society of North America, American Association for the History of Medicine, American Orthopaedic Society for Sports Medicine, Massachusetts Medical Society

Disclosure: Received consulting fee from Smith & Nephew Endoscopy for consulting; Received consulting fee from EBI Biomet for consulting; Received consulting fee from OrthoPediatrics for consulting; Received stock from Pivot Medical for consulting; Received consulting fee from pediped for consulting; Received royalty from WB Saunders for none; Received stock from Fixes-4-Kids for consulting.

References
  1. Smoker WR, Khanna G. Imaging the craniocervical junction. Childs Nerv Syst. 2008 Oct. 24(10):1123-45. [Medline].

  2. J. M. Parrot. Les malformations achondrodysplasiques. Bulletins de la Société d’anthropologie de Paris, 1878. 1878.

  3. Bailey JA 2nd. Orthopaedic aspects of achondroplasia. J Bone Joint Surg Am. 1970 Oct. 52(7):1285-301. [Medline].

  4. Nelson MA. Orthopaedic aspects of the chondrodystrophies. The dwarf and his orthopaedic problems. Ann R Coll Surg Engl. 1970 Oct. 47(4):185-210. [Medline].

  5. Horton WA, Hall JG, Hecht JT. Achondroplasia. Lancet. 2007 Jul 14. 370(9582):162-72. [Medline].

  6. Laederich MB, Horton WA. Achondroplasia: pathogenesis and implications for future treatment. Curr Opin Pediatr. 2010 Aug. 22(4):516-23. [Medline].

  7. Baitner AC, Maurer SG, Gruen MB, Di Cesare PE. The genetic basis of the osteochondrodysplasias. J Pediatr Orthop. 2000 Sep-Oct. 20(5):594-605. [Medline].

  8. Wang Q, Green RP, Zhao G, Ornitz DM. Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains. Development. 2001 Oct. 128(19):3867-76. [Medline].

  9. Carakushansky G, Rosembaum S, Ribeiro MG, et al. Achondroplasia associated with Down syndrome. Am J Med Genet. 1998 May 1. 77(2):168-9. [Medline].

  10. Wynn J, King TM, Gambello MJ, Waller DK, Hecht JT. Mortality in achondroplasia study: A 42-year follow-up. Am J Med Genet A. 2007 Nov 1. 143(21):2502-11. [Medline].

  11. Hoover-Fong JE, McGready J, Schulze KJ, Barnes H, Scott CI. Weight for age charts for children with achondroplasia. Am J Med Genet A. 2007 Oct 1. 143(19):2227-35. [Medline].

  12. Hoover-Fong JE, Schulze KJ, McGready J, Barnes H, Scott CI. Age-appropriate body mass index in children with achondroplasia: interpretation in relation to indexes of height. Am J Clin Nutr. 2008 Aug. 88(2):364-71. [Medline].

  13. Ireland PJ, McGill J, Zankl A, et al. Functional performance in young Australian children with achondroplasia. Dev Med Child Neurol. 2011 Oct. 53(10):944-50. [Medline].

  14. Ireland PJ, Johnson S, Donaghey S, Johnston L, Ware RS, Zankl A, et al. Medical management of children with achondroplasia: Evaluation of an Australasian cohort aged 0-5 years. J Paediatr Child Health. 2011 Nov 23. [Medline].

  15. Lonstein JE. Treatment of kyphosis and lumbar stenosis in achondroplasia. Basic Life Sci. 1988. 48:283-92. [Medline].

  16. Cohen ME, Rosenthal AD, Matson DD. Neurological abnormalities in achondroplastic children. J Pediatr. 1967 Sep. 71(3):367-76. [Medline].

  17. Modaff P, Horton VK, Pauli RM. Errors in the prenatal diagnosis of children with achondroplasia. Prenat Diagn. 1996 Jun. 16(6):525-30. [Medline].

  18. Morgan DF, Young RF. Spinal neurological complications of achondroplasia. Results of surgical treatment. J Neurosurg. 1980 Apr. 52(4):463-72. [Medline].

  19. Erdincler P, Dashti R, Kaynar MY, et al. Hydrocephalus and chronically increased intracranial pressure in achondroplasia. Childs Nerv Syst. 1997 Jun. 13(6):345-8. [Medline].

  20. Lugo N, Becker J, Van Bosse H, et al. Lung volume histograms after computed tomography of the chest with three-dimensional imaging as a method to substantiate successful surgical expansion of the rib cage in achondroplasia. J Pediatr Surg. 1998 May. 33(5):733-6. [Medline].

  21. Song HR, Choonia AT, Hong SJ, Lee SH, Suh SW, Cha IH. Rotational profile of the lower extremity in achondroplasia: computed tomographic examination of 25 patients. Skeletal Radiol. 2006 Dec. 35(12):929-34. [Medline].

  22. Jeong ST, Song HR, Keny SM, Telang SS, Suh SW, Hong SJ. MRI study of the lumbar spine in achondroplasia. A morphometric analysis for the evaluation of stenosis of the canal. J Bone Joint Surg Br. 2006 Sep. 88(9):1192-6. [Medline].

  23. Rollins N, Booth T, Shapiro K. The use of gated cine phase contrast and MR venography in achondroplasia. Childs Nerv Syst. 2000 Sep. 16(9):569-75; discussion 575-7. [Medline].

  24. Moritani T, Aihara T, Oguma E, Makiyama Y, Nishimoto H, Smoker WR. Magnetic resonance venography of achondroplasia: correlation of venous narrowing at the jugular foramen with hydrocephalus. Clin Imaging. 2006 May-Jun. 30(3):195-200. [Medline].

  25. Mehta A, Hindmarsh PC. The use of somatropin (recombinant growth hormone) in children of short stature. Paediatr Drugs. 2002. 4(1):37-47. [Medline].

  26. Bell DF, Boyer MI, Armstrong PF. The use of the Ilizarov technique in the correction of limb deformities associated with skeletal dysplasia. J Pediatr Orthop. 1992 May-Jun. 12(3):283-90. [Medline].

  27. Brooks WC, Gross RH. Genu Varum in Children: Diagnosis and Treatment. J Am Acad Orthop Surg. 1995 Nov. 3(6):326-335. [Medline].

  28. Gil Z, Tauman R, Sivan J, et al. [Neurosurgical aspects in achondroplasia: evaluation and treatment]. Harefuah. 2001 Nov. 140(11):1026-31, 1118. [Medline].

  29. Kashiwagi N, Suzuki S, Seto Y, Futami T. Bilateral humeral lengthening in achondroplasia. Clin Orthop. 2001 Oct. (391):251-7. [Medline].

  30. Mamada K, Nakamura K, Matsushita T, et al. The diameter of callus in leg lengthening: 28 tibial lengthenings in 14 patients with achondroplasia. Acta Orthop Scand. 1998 Jun. 69(3):306-10. [Medline].

  31. Paley D. Current techniques of limb lengthening. J Pediatr Orthop. 1988 Jan-Feb. 8(1):73-92. [Medline].

  32. Peretti G, Memeo A, Paronzini A, Marzorati S. Staged lengthening in the prevention of dwarfism in achondroplastic children: a preliminary report. J Pediatr Orthop B. 1995. 4(1):58-64. [Medline].

  33. Pyeritz RE, Sack GH Jr, Udvarhelyi GB. Thoracolumbosacral laminectomy in achondroplasia: long-term results in 22 patients. Am J Med Genet. 1987 Oct. 28(2):433-44. [Medline].

  34. Ravenscroft A, Rout C. Epidural anaesthesia for caesarean section in an achondroplastic dwarf. Br J Anaesth. 1999 Feb. 82(2):301-3. [Medline].

  35. Lee SH, Modi HN, Song HR, Hazra S, Suh SW, Modi C. Deceleration in maturation of bone during adolescent age in achondroplasia-a retrospective study using RUS scoring system. Skeletal Radiol. 2008 Jul 16. [Medline].

  36. Lee ST, Song HR, Mahajan R, Makwana V, Suh SW, Lee SH. Development of genu varum in achondroplasia: relation to fibular overgrowth. J Bone Joint Surg Br. 2007 Jan. 89(1):57-61. [Medline].

  37. Kim SJ, Agashe MV, Song SH, Choi HJ, Lee H, Song HR. Comparison between upper and lower limb lengthening in patients with achondroplasia: a retrospective study. J Bone Joint Surg Br. 2012 Jan. 94(1):128-33. [Medline].

  38. Schiedel F, Rödl R. Lower limb lengthening in patients with disproportionate short stature with achondroplasia: a systematic review of the last 20 years. Disabil Rehabil. 2011 Nov 23. [Medline].

  39. Koczewski P, Shadi M. [Surgical treatment of short stature of different etiology by the Ilizarov method]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2007. 13(3):143-6. [Medline].

  40. American Academy of Pediatrics Committee on Genetics. Health supervision for children with achondroplasia. Pediatrics. 1995 Mar. 95(3):443-51. [Medline].

 
Previous
Next
 
Typical features of person with achondroplastic dwarfism, including normal trunk with rhizomelic shortening and genu varum.
Characteristic skull seen in patients with achondroplasia, with frontal bossing, small foramen magnum, midface hypoplasia, and relative enlargement of skull as compared with face.
Progressive narrowing of coronal interpedicular distance in lumbar spine in patients with achondroplasia. Note characteristic shape of pelvis with horizontal sacral position.
Thoracolumbar kyphosis with narrow lumbar spinal canal and concave posterior bodies in 13-month-old child with achondroplasia.
Typical features of lower limbs in person with achondroplasia, including horizontal acetabular roofs, small sacrosciatic notches, genu varum and ankle varum with relative overgrowth of fibula, and inverted V-shaped distal femoral physis.
MRI showing cervicomedullary compression at foramen magnum in patient with achondroplasia.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.